If the FDA will require outcomes trials for future approvals in obesity, this will add considerable time and cost to drug development
More than 40 percent stop after just four weeks, according to research released by BCBSA and conducted by BHI
With a wide range of plausible effectiveness and costs of behavioral intervention, this alternative program was projected to generate substantial savings in net healthcare costs, with minimal loss of health-related quality of life
The safety of microdosing GLP-1 medications is not well-established, Stanford said
Well guide grocery shopping on a budget, meal planning, and making nutritious choices that wont break the bank
GLP-1 tablets may lead to more variable absorption patterns, particularly in the early weeks of therapy